Product	Catalog No	Product Insert
gASCA IgG	S701100	click for pdf
ALCA IgG	L703011	click for pdf
ACCA IgA	C702100	click for pdf
AMCA IgG	M704100	click for pdf
Anti-C IgA	AC706100	click for pdf
Anti-L IgA	AL707100	click for pdf

• Higher sensitivity

  ~ 80% sensitivity. More than any other IBD test on the market.

  Identifies ASCA negative Crohn’s disease patients

  The IBDX^® can identify between 35% to 56.4% of ASCA negative CD patients.

• Higher specificity

  Employing gASCA, second generation of ASCA using advanced sugar technology, in combination with Anti-L, Anti-C, ALCA, ACCA and AMCA allows for 90-99% specificity for Chron's Disease

• Predict Disease Outcome

  The IBDX^® predict complications and need for abdominal surgery in Chron's disease patients as well as pouchitis in Ulcerative Colitis post-Op IPAA patients

• Pediatric value

  IBDX^® is fully validated for the pediatric population

The Management and staff of Glycominds are committed to meeting or exceeding our customer's expectations and all relevant regulatory requirements and to being a supplier known for the quality of every product and service we provide.

Our products and services shall be consistently safe for use, uniformly produced, and delivered on time.

This is a joint responsibility shared by each member of our organization. We are dedicated to continuous improvement of our overall quality performance in every facet of our operations and this dedication is manifested by the periodic establishment and achievement of quality goals and objectives at all levels of the organization.

We have established and implemented a system of quality in line with ISO 13485 international standards, and we regard this system as a means of continually improving our production and processes. >>

MDSS GmbH >>

Schiffgraben 41
30175 Hannover
Germany

Phone: (+49)-511-6262 8630
FAX: (+49) -511-6262 8633